Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
Takuo YamaiKenji IkezawaErika HiragaYasuharu KawamotoTakeru HiraoSena HigashiKazuma DaikuShingo MaedaYutaro AbeMakiko UrabeYugo KaiRyoji TakadaTasuku NakaboriNobuyasu FukutakeHiroyuki UeharaMasashi FujitaKazuyoshi OhkawaPublished in: PloS one (2022)
Early VTE detection is a predictor of a poor prognosis in UR-MPC patients who receive GnP as first-line chemotherapy, suggesting that screening VTE for patients with UR-MPC is crucial, even if patients are asymptomatic.
Keyphrases
- poor prognosis
- venous thromboembolism
- locally advanced
- long non coding rna
- squamous cell carcinoma
- direct oral anticoagulants
- rectal cancer
- end stage renal disease
- ejection fraction
- radiation therapy
- newly diagnosed
- chemotherapy induced
- small cell lung cancer
- prognostic factors
- peritoneal dialysis
- advanced non small cell lung cancer
- patient reported
- loop mediated isothermal amplification
- tyrosine kinase